Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 1

3(42.9%)

N/A

2(28.6%)

Phase 4

2(28.6%)

7Total

Phase 1(3)

N/A(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07052942Phase 4Recruiting

Individualizing Treatment for Asthma in Primary Care (Full Study)

Role: collaborator

NCT06272370Phase 4Completed

Individualizing Treatment for Asthma in Primary Care

Role: collaborator

NCT00308724Not ApplicableCompleted

Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care

Role: collaborator

NCT03671785Phase 1Completed

Study of the Fecal Microbiome in Patients With Parkinson's Disease

Role: collaborator

NCT02449174Phase 1Completed

Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route

Role: collaborator

NCT03026231Phase 1Withdrawn

Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients

Role: collaborator

NCT00201084Not ApplicableCompleted

Physician Uncertainty Reduction for Hypertension

Role: collaborator

All 7 trials loaded